Podcast U.S. Vaccine Policy Shifts Create a “Chilling” Effect on Global Manufacturing and Innovation 23 February 2026
Content China Biopharma Out-Licensing Surges to Record $137.7B in 2025, 2026 on Pace to Break It Again 20 February 2026
Chart Continuous Bioprocessing Market to Reach $2.3B by 2035, Driven by Biosimilar Pressure and Mega-Site Investment 17 February 2026
